A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma

被引：10

作者：

Jabulowsky, Robert A. ^{[1
]}

Loquai, Carmen ^{[2
]}

Mitzel-Rink, Heidrun ^{[2
]}

Utikal, Jochen ^{[3
,4
]}

Gebhardt, Christoffer ^{[3
,4
]}

Hassel, Jessica C. ^{[5
]}

Kaufmann, Roland ^{[6
]}

Pinter, Andreas ^{[6
]}

Derhovanessian, Evelyna ^{[1
]}

Anft, Christine ^{[1
]}

Attig, Sebastian ^{[7
]}

Deubel, Alexandra ^{[1
]}

Diken, Mustafa ^{[7
]}

Gold, Maike ^{[1
]}

Guertler, Claudia ^{[1
]}

Haas, Heinrich ^{[1
]}

Heesen, Ludwig ^{[1
]}

Kemmer-Brueck, Alexandra ^{[1
]}

Kranz, Lena M. ^{[1
]}

Kuehlcke, Klaus ^{[1
]}

Kuhn, Andreas ^{[1
]}

Langguth, Peter ^{[1
]}

Luxemburger, Ulrich ^{[1
]}

Maurus, Daniel ^{[1
]}

Meng, Martin ^{[1
]}

Mueller, Felicitas ^{[1
]}

Rae, Richard ^{[6
,7
]}

Sari, Fatih ^{[1
]}

Schreeb, Katharina ^{[1
]}

Schwarck-Kokarakis, Doreen ^{[1
]}

Stein, Malte ^{[1
]}

Jaeger, Dirk ^{[8
]}

Grabbe, Stephan ^{[2
]}

Kreiter, Sebastian ^{[6
,7
]}

Huber, Christoph ^{[1
]}

Tuereci, Oezlem ^{[9
]}

Sahin, Ugur ^{[1
]}

机构：

[1] BioNTech Corp, Mainz, Germany

[2] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany

[3] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany

[4] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany

[5] Heidelberg Univ Hosp, NCT Heidelberg, Dept Dermatol, Heidelberg, Germany

[6] Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany

[7] Univ Med Ctr Mainz gGmbH, TRON Translat Oncol, Mainz, Germany

[8] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Med Oncol, Heidelberg, Germany

[9] Cluster Individualized Immune Intervent, Mainz, Germany

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-CT156

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT156

引用

页数：3

共 37 条

[21] Phase I First-In-Human Trial of DCR-PH1, a novel short interfering RNA (siRNA) formulated in lipid nanoparticles (LNP), for the treatment of Primary Hyperoxaluria type 1 (PH1)
Pano, A.
Dickerson, D.
Fielman, B.
Lockridge, J. A.
Brown, B. D.
Bhargava, P.
PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1888 - 1888
[22] Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Adamina, Michel
Weber, Walter P.
Rosenthal, Rachel
Schumacher, Reto
Zajac, Paul
Guller, Ulrich
Frey, Daniel M.
Oertli, Daniel
Zuber, Markus
Heberer, Michael
Spagnoli, Giulio C.
CONTEMPORARY CLINICAL TRIALS, 2008, 29 (02) : 165 - 181
[23] A phase i/ii clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human fix for haemophilia b gene therapy
Nathwani, Amit C.
Tuddenham, Edward G. D.
Rosales, Cecilia
Macintosh, Jenny
Chowdary, Pratima
Riddell, Anne
Aghighi, Saman
Lilley, Patricia
Yee, Thynn
Griffioen, Anja
Pie, Jun
Harrington, Chris
Glader, Bert
Ng, Catherine Y. C.
Kaye, Mark
Zhou, Junfang
Allay, James
Coleman, John
Sleep, Susan
High, Katherine
Mingozzi, Federico
Gray, John T.
Reiss, Ulrike M.
Nienhuis, Arthur W.
Davidoff, Andrew M.
HUMAN GENE THERAPY, 2011, 22 (06) : A7 - A8
[24] A Phase I/II clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human FIX for Haemophilia B gene therapy
Nathwani, A.
Tuddenham, E. G. D.
Rosales, C.
Macintosh, J.
Chowdary, P.
Riddell, A.
Aghighi, S.
Griffioen, A.
Pie, J.
Harrington, C.
Glader, B.
Ng, C. Y. C.
Kay, M.
Zhou, J.
Allay, J.
Coleman, J.
Sleep, S.
High, K.
Mingozzi, F.
Gray, J. T.
Reiss, U. M.
Nienhuis, A. W.
Davidoff, A. M.
HUMAN GENE THERAPY, 2011, 22 (10) : A20 - A20
[25] First-in-human phase I clinical trial of RSO-021, a first-in class covalent inhibitor of mitochondrial peroxiredoxin 3 (PRX3), in patients with malignant pleural effusion due to mesothelioma and other advanced solid tumors (MITOPE).
Fennell, Dean Anthony
Dulloo, Sean
Lord, Simon
Thistlethwaite, Fiona
Blyth, Kevin G.
Szlosarek, Peter Wojciech
Maskell, Nick
Popat, Sanjay
Aujayeb, Avinash
Aktas, Burak Y.
Javed, Sohail Rooman
Colomina, Julio Herrero
Cunniff, Brian
Duncan, Jarrett
Graham, Philippa
Bexon, Alice Susannah
Naumov, George N.
Spicer, James F.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[26] First-in-human phase I/IIa clinical trial of ZV0203, a novel pertuzumab-based antibody-drug conjugate (ADC), in patients (pts) with Her2 positive advanced solid
Lin, F.
Huang, Y.
Huang, Y.
Lu, Y.
Rao, X.
Wang, X.
Wang, F.
Huang, X.
ANNALS OF ONCOLOGY, 2024, 35 : S354 - S355
[27] FIRST-IN-HUMAN PHASE 1 STUDY OF CD200 ACTIVATION RECEPTOR-LIGAND (CD200AR-L) AND ALLOGENEIC TUMOR LYSATE VACCINE IMMUNOTHERAPY FOR RECURRENT GLIOBLASTOMA: INITIAL RESULTS FROM AN ONGOING CLINICAL TRIAL
Neil, Elizabeth
Eaton, Anne
Lunn, Shannon
Nelson, Kristen
Greengard, Emily
Moertel, Christopher
Olin, Michael
NEURO-ONCOLOGY, 2021, 23 : 52 - 53
[28] Immune activation with a novel immune switch anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in phase I/II first-in-human MATINS trial in patients with advanced solid tumours
Bono, P.
Hollmen, M.
Jaakkola, P.
Shetty, S.
Thibault, A.
de Jonge, M. J. A.
Minchom, A. R.
Ma, Y. T.
Yap, C.
Robbrecht, D.
Pasanen, A.
Jalkanen, S.
Cruz, R.
Pal, A.
Karvonen, M. K.
Mandelin, J.
Koivunen, J.
ANNALS OF ONCOLOGY, 2019, 30
[29] Safety, tolerability, and efficacy of the novel intravenous manganese-based contrast agent SN132D in patients with breast cancer: initial results of a Phase I, First-In-Human clinical trial SPAGOPIX-01
Warnberg, Fredrik
Karakatsanis, Andreas
Shcherbina, Liliya
Sjoberg, Folke
Hargreaves, Paul
Curiac, Ioan-Dan
Johansson, Edvin
Axelsson, Oskar
Hansen, Mats
CANCER RESEARCH, 2023, 83 (05)
[30] A novel fully human anti-CD20 monoclonal antibody. First clinical results from an ongoing phase I/II trial in patients with follicular non-Hodgkin's lymphoma
Hagenbeek, A
Plesner, T
Walewski, J
Kneba, M
Petersen, J
Radford, J
ANNALS OF ONCOLOGY, 2005, 16 : 71 - 71

← 1 2 3 4 →